• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测急诊科 COVID-19 出院患者 30 天结局。

Predicting 30 - Day outcomes in emergency department patients discharged with COVID-19.

机构信息

Temple/St. Luke's Medical School, 801 Ostrum Street, Bethlehem, PA 18015, United States.

St. Luke's University Health Network, 801 Ostrum Street, Bethlehem, PA 18015, United States.

出版信息

Am J Emerg Med. 2021 Dec;50:513-517. doi: 10.1016/j.ajem.2021.08.077. Epub 2021 Sep 2.

DOI:10.1016/j.ajem.2021.08.077
PMID:34537576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8410217/
Abstract

INTRODUCTION

Determining disposition for COVID-19 patients can be difficult for emergency medicine clinicians. Previous studies have demonstrated risk factors which predict severe infection and mortality however little is known about which risk factors are associated with failure of outpatient management and subsequent admission for COVID-19 patients.

METHODS

We conducted a retrospective observational chart review of patients who had a confirmed positive COVID-19 test collected during an ED visit between March 1, 2020 and October 11, 2020. Patients were divided into two groups based on presence or absence of a subsequent 30-day hospitalization. Clinical and demographic information were collected including chief complaint, triage vital signs and comorbid medical conditions.

RESULTS

1038 patients were seen and discharged from a network ED with a positive SARS-CoV-2 PCR test. 94 patients (9.1%) were admitted to a hospital within 30 days of the index ED visit while 944 (90.9%) were not admitted to a network hospital within 30 days. Patients that were admitted were more likely to be older (aOR = 1.04 (95% CI 1.03-1.06)), hypoxic (aOR = 2.16 (95% CI 1.14-4.10)) and tachycardic (aOR = 2.13 (95% CI 1.34-3.38)) on initial ED presentation. Preexisting hypertension, diabetes mellitus, coronary artery disease, chronic kidney disease and malignancy were all highly significant risk factors for 30-day hospital admission following initial ED discharge (p < 0.0001).

CONCLUSION

Emergency Department providers should consider age, chief complaint, vital signs and comorbid medical conditions when determining disposition for patients diagnosed with COVID-19.

摘要

简介

对于急诊医学临床医生来说,确定 COVID-19 患者的处置方式可能具有挑战性。先前的研究已经证明了预测严重感染和死亡率的危险因素,但是对于哪些危险因素与 COVID-19 患者门诊管理失败和随后入院相关知之甚少。

方法

我们对 2020 年 3 月 1 日至 2020 年 10 月 11 日期间在急诊科就诊且采集了确诊的 COVID-19 检测样本的患者进行了回顾性观察性图表审查。根据是否存在随后的 30 天住院情况,将患者分为两组。收集了临床和人口统计学信息,包括主要诉求、分诊生命体征和合并症。

结果

共有 1038 例患者在网络急诊部就诊,他们的 SARS-CoV-2 PCR 检测结果为阳性。在指数 ED 就诊后 30 天内,94 例(9.1%)患者被收治住院,而 944 例(90.9%)患者未在网络医院住院。住院患者更可能年龄较大(OR = 1.04(95%CI 1.03-1.06))、缺氧(OR = 2.16(95%CI 1.14-4.10))和心动过速(OR = 2.13(95%CI 1.34-3.38))。在急诊科初次就诊时,高血压、糖尿病、冠状动脉疾病、慢性肾脏病和恶性肿瘤等合并症都是 30 天内住院的高度显著危险因素(p < 0.0001)。

结论

急诊科医生在为 COVID-19 患者确定处置方式时,应考虑年龄、主要诉求、生命体征和合并症。

相似文献

1
Predicting 30 - Day outcomes in emergency department patients discharged with COVID-19.预测急诊科 COVID-19 出院患者 30 天结局。
Am J Emerg Med. 2021 Dec;50:513-517. doi: 10.1016/j.ajem.2021.08.077. Epub 2021 Sep 2.
2
Clinical Characteristics Associated with Return Visits to the Emergency Department after COVID-19 Diagnosis.临床特征与 COVID-19 诊断后急诊复诊相关。
West J Emerg Med. 2021 Nov 5;22(6):1257-1261. doi: 10.5811/westjem.2021.9.52824.
3
Predictors of readmission requiring hospitalization after discharge from emergency departments in patients with COVID-19.COVID-19 患者出院后再次住院需要住院治疗的预测因素。
Am J Emerg Med. 2021 Aug;46:146-149. doi: 10.1016/j.ajem.2021.04.055. Epub 2021 Apr 22.
4
Clinical characteristics and management of COVID-19 patients accessing the emergency department in a hospital in Northern Italy in March and April 2020.2020 年 3 月至 4 月意大利北部一家医院急诊科就诊的 COVID-19 患者的临床特征和管理。
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):208-215. doi: 10.19191/EP20.5-6.S2.120.
5
Risk Stratification of COVID-19 Patients Using Ambulatory Oxygen Saturation in the Emergency Department.使用急诊科门诊血氧饱和度对 COVID-19 患者进行风险分层。
West J Emerg Med. 2020 Sep 24;21(6):5-14. doi: 10.5811/westjem.2020.8.48701.
6
Predictors of pediatric emergency patients discharged against medical advice.违背医嘱出院的儿科急诊患者的预测因素。
Clin Pediatr (Phila). 2009 Apr;48(3):263-70. doi: 10.1177/0009922808323109. Epub 2008 Oct 2.
7
Outcomes of patients discharged from the pediatric emergency department with abnormal vital signs.儿科急诊部门中生命体征异常患者的出院结果。
Am J Emerg Med. 2022 Jul;57:76-80. doi: 10.1016/j.ajem.2022.04.021. Epub 2022 Apr 26.
8
Factors associated with revisits by patients with SARS-CoV-2 infection discharged from a hospital emergency department.与从医院急诊科出院的 SARS-CoV-2 感染患者复诊相关的因素。
Emergencias. 2020 Nov;32(6):386-394.
9
Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients.出院后 COVID-19 存活者:家庭健康接受者的症状、功能和不良结局。
Ann Intern Med. 2021 Mar;174(3):316-325. doi: 10.7326/M20-5206. Epub 2020 Nov 24.
10
Characteristics and outcomes of patients with COVID-19 who return to the emergency department: a multicentre observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN).COVID-19 患者返回急诊科的特征和结局:加拿大 COVID-19 急诊科快速反应网络(CCEDRRN)的一项多中心观察性研究。
Emerg Med J. 2024 Mar 21;41(4):210-217. doi: 10.1136/emermed-2023-213277.

引用本文的文献

1
Derivation and validation of a clinical decision rule to risk-stratify COVID-19 patients discharged from the emergency department: The CCEDRRN COVID discharge score.急诊科出院的COVID-19患者风险分层临床决策规则的推导与验证:CCEDRRN COVID出院评分
J Am Coll Emerg Physicians Open. 2022 Dec 22;3(6):e12868. doi: 10.1002/emp2.12868. eCollection 2022 Dec.
2
Age-related differences in symptoms in older emergency department patients with COVID-19: Prevalence and outcomes in a multicenter cohort.老年 COVID-19 急诊科患者症状的年龄相关性差异:多中心队列研究的患病率和结局。
J Am Geriatr Soc. 2022 Jul;70(7):1918-1930. doi: 10.1111/jgs.17816. Epub 2022 Apr 29.
3
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.干扰素 β-1a 联合瑞德西韦与单用瑞德西韦治疗住院 COVID-19 成人患者的疗效比较:一项双盲、随机、安慰剂对照、3 期临床试验。
Lancet Respir Med. 2021 Dec;9(12):1365-1376. doi: 10.1016/S2213-2600(21)00384-2. Epub 2021 Oct 18.

本文引用的文献

1
Practical protocols for managing patients with SARS-CoV-2 infection (COVID-19) in the emergency department.急诊科管理 SARS-CoV-2 感染(COVID-19)患者的实用方案。
Emerg Med Pract. 2021 Feb 22;23(Suppl 2):1-38.
2
Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020.2020 年美国科罗拉多州住院和非住院的冠状病毒疾病患者的症状特征和进展情况。
Emerg Infect Dis. 2021 Feb;27(2):385-395. doi: 10.3201/eid2702.203729.
3
Natural history of COVID-19 and therapeutic options.COVID-19 的自然史和治疗选择。
Expert Rev Clin Immunol. 2020 Dec;16(12):1159-1184. doi: 10.1080/1744666X.2021.1847640. Epub 2020 Dec 24.
4
Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients.新冠病毒感染患者的风险因素预测、临床结局和死亡率。
J Med Virol. 2021 Apr;93(4):2307-2320. doi: 10.1002/jmv.26699. Epub 2020 Dec 17.
5
Aging in COVID-19: Vulnerability, immunity and intervention.COVID-19 相关衰老问题:脆弱性、免疫与干预。
Ageing Res Rev. 2021 Jan;65:101205. doi: 10.1016/j.arr.2020.101205. Epub 2020 Oct 31.
6
COVID-19: Discovery, diagnostics and drug development.新型冠状病毒肺炎:发现、诊断和药物研发。
J Hepatol. 2021 Jan;74(1):168-184. doi: 10.1016/j.jhep.2020.09.031. Epub 2020 Oct 8.
7
Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study.COVID-19 住院患者的患者轨迹:一项队列研究。
Ann Intern Med. 2021 Jan;174(1):33-41. doi: 10.7326/M20-3905. Epub 2020 Sep 22.
8
Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive review.新型冠状病毒肺炎的微观结构、病理生理学和潜在治疗方法:全面综述。
J Med Virol. 2021 Jan;93(1):275-299. doi: 10.1002/jmv.26254. Epub 2020 Jul 15.
9
Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.2019 年冠状病毒病病例监测-美国,2020 年 1 月 22 日-5 月 30 日。
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765. doi: 10.15585/mmwr.mm6924e2.
10
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.